Navigation Links
Eliminating Cellulite

WALTHAM, Mass., Millennium Research Group (MRG) has conducted a detailed analysis of the US aesthetics lasers market in its US Markets for Aesthetics Lasers and Energy Devices 2007 report. The analysis reveals that over the next five years more women will be receiving cellulite reduction procedures as noninvasive cellulite reduction products receive over- the-counter FDA approvals. In 2006, 330,000 people in the US received laser and energy device assisted cellulite reduction procedures, and by 2011 that number will more than double.

While most aesthetic laser procedures require some level of physician supervision or intervention, a number of noninvasive cellulite reduction devices will gain over the counter approval by the FDA. Over the counter cellulite reduction devices will be readily adopted in spas because they garner significantly higher overall profit margins versus most spa based procedures.

"Although cellulite occurs in individuals of varying weights, cellulite severity is correlated with increased weight. In the US, the average weight is increasing annually, particularly in younger generations, thereby expanding the population pool for cellulite reduction treatment," says Jaya Classen, senior analyst at MRG. "The expanding patient pool combined with increasing awareness and acceptance of medical cellulite reduction procedures, will drive growth in this market through 2011 and beyond."

The US Markets for Aesthetics Lasers and Energy Devices 2007 report includes coverage of key industry competitors, including Candela Corporation, Lumenis, Palomar Medical Technologies, Cutera, Alma Lasers, Syneron, and Reliant.

About Cellulite

Cellulite is the collection of fat pockets that give the skin a dimpling, orange peel-like appearance. Cellulite occurs more frequently in women than men because cellulite is associated with increased estrogen levels; the most common areas affected are the abdomen, thighs, and buttocks.

Nearly 90% of women over the age of 16 experience some degree of cellulite, and although its severity is correlated with obesity, cellulite can occur in an individual of any weight.


'"/>




Related medicine news :

1. Eliminating Eye Infection With Antibiotics
2. Eliminating Eye Infection With Antibiotics
3. India Targets Eliminating Leprosy
4. Palatal Implant Procedure Proven Effective in Eliminating Snoring
5. Period Eliminating Pills
6. New Gene Therapy may Be Helpful in Eliminating Arthritis Pain
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/22/2017)... ... February 22, 2017 , ... ... in recent years. The technology is so cutting edge, in fact, the U.S. ... for stem cell procedures. However, successful patient outcomes in certain clinical stem cell ...
(Date:2/22/2017)... CRANBURY, N.J. (PRWEB) , ... February 22, 2017 ... ... than a one-size-fits-all approach, leads to fewer trips the emergency room, fewer hospital ... in The American Journal of Managed Care® (AJMC®) finds. The study can be ...
(Date:2/22/2017)... Shrewsbury, PA (PRWEB) , ... February 22, 2017 , ... ... 2017 where the company met national TV host Tom Seay and his production crew. ... is a favorite among equestrians around the world. Saddle Sidekicks will be featured ...
(Date:2/22/2017)... ... February 22, 2017 , ... ... to Quality Insights to help small practices in Delaware, New Jersey, Pennsylvania and ... by the Medicare Access and CHIP Reauthorization Act of 2015 (MACRA). , ...
(Date:2/22/2017)... ... February 22, 2017 , ... Forty-five percent ... those report that family members or friends have also commented about their poor ... loss wear hearing aids. One reason, suggested by 89 percent of American respondents, ...
Breaking Medicine News(10 mins):
(Date:2/23/2017)... , February 23, 2017 The ... Market are GE Healthcare, Koninklijke Philips N.V., and Schiller. ... in the global market in 2015. Strong product portfolio ... factors assessed to be aiding these players remain leaders ... that the players in the global market are likely ...
(Date:2/23/2017)... Tillotts Pharma is strengthening its ... office was opened in January 2017 under ... includes Entocort ® for the treatment of Crohn,s ... colitis, and VistaPrep ® for bowel preparation before ... company focused on the treatment of gastrointestinal (GI) diseases ...
(Date:2/23/2017)... and VANCOUVER, British Columbia , ... OGXI ) today announced its year end 2016 ... In January 2017, OncoGenex, and Achieve Life Science, Inc., ... have entered into a definitive merger agreement under which ... completion of the proposed merger, Achieve,s stockholders are expected ...
Breaking Medicine Technology: